Caffeine market in China to rise at 5.6% CAGR till 2027
2022-05-08 01:35:48 UTC | Healthcare & Pharmaceuticals
Caffeine is the world's most popular drug. It is the most commonly consumed psychoactive substance in the world. Caffeine is a substance that is naturally produced in the leaves and seeds of many plants, including coffee beans, guarana, yerba maté, cacao beans, and tea. Caffeine is determined as a drug because it is a central nervous system stimulant. It is used to provide a boost of energy, causing increased alertness. Caffeine gives most people a temporary energy boost and elevates mood, and is also used to stay awake longer. Caffeine (C8H10N4O2) is the common name for trimethylxanthine. It is a bitter, white crystalline xanthine alkaloid that is a psychoactive stimulant drug. Caffeine was discovered by a German chemist, Friedrich Ferdinand Runge, in 1819. He coined the term kaffein, a chemical compound in coffee, which in English became caffeine. Caffeine is also part of the chemical mixtures and insoluble complexes guaranine found in guarana, mateine found in mate, and theine found in non-herbal tea; all of which contain additional alkaloids such as the cardiac stimulants theophylline and theobromine, and often other chemicals such as polyphenols which can form insoluble complexes with caffeine. The caffeine market in China, in terms of revenue, is expected to grow by 5.6 percent annually through 2027, according to a new report by Gen Consulting Company.
The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into caffeine market in China. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the caffeine industry.
This industry report offers market estimates and forecasts of the China market, followed by a detailed analysis of the application. The China market for caffeine can be segmented by application: pharmaceuticals, cosmetics, food & beverages.
By application:
- pharmaceuticals
- cosmetics
- food & beverages
The caffeine in China market report offers detailed information on several market vendors, including CSPC Pharmaceutical Group Ltd., Jilin Shulan Synthetic Pharmaceutical Co., Ltd., Jiuquan Dadeli Pharmaceutical Co. Ltd., Shandong Xinhua Pharmaceutical Co., Ltd., Tianjin Zhongan Pharmaceutical Co., Ltd., Youhua Pharmaceutical (Leshan) Co., Ltd., among others.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
Historical & Forecast Period
This research report provides analysis for each segment from 2017 to 2027 considering 2020 to be the base year.
Scope of the Report
- To analyze and forecast the market size of the caffeine market in China.
- To classify and forecast the caffeine market in China based on application.
- To identify drivers and challenges for the caffeine market in China.
- To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the caffeine market in China.
- To identify and analyze the profile of leading players operating in the caffeine market in China.
Why Choose This Report
- Gain a reliable outlook of the caffeine market in China forecasts from 2021 to 2027 across scenarios.
- Identify growth segments for investment.
- Stay ahead of competitors through company profiles and market data.
- The market estimate for ease of analysis across scenarios in Excel format.
- Strategy consulting and research support for three months.
- Print authentication provided for the single-user license.
